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ABSTRACT 
 The purpose of this study is to approximate hybridoma growth kinetic model 
by comparing simulation result from SuperPro Designer® and experimental result.  
Modeling of hybridoma include calculation of mass for 1 cell and its density. Two 
kinetic models tested in this study; experimental correlation and de Tremblay et al. 
(1992). Simplification need to be made as this will allow selected model to be used 
in SPD. Value of µmax, KsGLN, KsGLC  are 1.09 d-1 (0.05 h-1), 0.3 mM (43.85 mg/L) 
and 0.1 mM (18.02 mg/L) respectively for de Tremblay and for experimental 
correlation, their values are 0.158 h-1, 0.0016 mM (0.23 mg/L)  and 12.05 mM 
(2170.93 mg/L) respectively.  Experimental data shows no stationary phase but 
simulation results show stationary phase.  From simulation, cell count of 195907.7 
while final concentration of glucose, glutamine, ammonia and lactate are 16.38, 4.07, 
3.01 and 5.59 mmol/L respectively (experimental correlation) and cell count of 
196185.73 while final concentration of glucose, glutamine, ammonia and lactate are 
10.73, 2.09, 6.07 and 11.30 mmol/L respectively (de Tremblay).  Serious deviations 
occurred because of simplification on de Tremblay model and inaccurate prediction 
of glutamine effect on hybridoma’s growth. Metabolic reaction used without taking 
hybridoma real behavior into account. Simulation shows exponential phase without 
having going through lag phase. 
 
 
 
 
 
 
 
  
iv 
 
ABSTRAK 
 Tujuan kajian ini adalah untuk mencari nilai terhampir bagi pemalar penting 
dalam model kinetik hibridoma dengan menbandingkan keputusan simulasi dari 
SuperPro Designer® dan keputusan eksperimen.  Pemodelan hibridoma melibatkan 
pengiraan jisim satu sel dan ketumpatannya.  Dua model kinetik telah diuji di dalam 
kajian ini; model dari eksperimen dan  de Tremblay et al. (1992).  Terdapat 
tanggapan perlu dibuat untuk membolehkan model yang dipilih boleh digunapakai 
bersama SPD.  Nilai bagi µmax, KsGLN, KsGLC  are 1.09 d-1 (0.05 h-1), 0.3 mM (43.85 
mg/L) and 0.1 mM (18.02 mg/L) mengikut urutan bagi de Tremblay dan untuk 
korrelasi experimen,  nilainya adalah 0.158 h-1, 0.0016 mM (0.23 mg/L)  and 12.05 
mM (2170.93 mg/L) mengikut urutan.  Data eksperimen menunjukkan tiada fasa 
statik tetapi data simulasi menunjukkan fasa statik.  Dari simulasi, kiraan sel ialah 
195907.7 manakala kepekatan akhir glukosa, glutamin, ammonia and laktik adalah 
16.38, 4.07, 3.01 and 5.59 mmol/L mengikut urutan (korrelasi eksperimen) dan 
kiraan sel ialah 196185.73 manakala kepekatan akhir  glukosa, glutamin, ammonia 
and laktik are 10.73, 2.09, 6.07 and 11.30 mmol/L mengikut urutan (de Tremblay).  
Ralat yang serius berlaku kerana adanya tanggapan terhadap model de Tremblay  
dan ramalan yang kurang tepat terhadap kesan glutamin kepada pertumbuhan 
hibridoma. Tindakbalas metabolik dipilih tanpa mengambilkira reaksi sebenar 
hybridoma terhadap substrak dan hasil metabolik. Fermentasi dalam SPD hanya 
mengambil kira fasa eksponential.   
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CHAPTER 1 
INTRODUCTION 
 1.1      Background of Study 
Monoclonal antibody (MAb) is an antibody of single type, i.e. will bind only to 
one antigen.  It is favored as pharmaceutical product because it can be administrated at 
high dosage because of low potency.  A.C.A Roque et al. (2004) has classified MAbs 
into three types. The first type is chimeric Mab, develop by joining DNA segment of 
mouse encoding variable region with human constant region.  Second type is transgenic 
MAb, obtained from genetically engineered animals and third type is recombinant 
antibody fragment, traditionally obtained by partial digestion of immonuglobulin with 
proteases.    Antigen detected including botulinum toxin, that cause muscular paralysis 
produce by Clostridum botulinum, been considered as bioterrorism agent (L.H Stanker et 
al. ,2008) and infection by B19 parnovirus that may case paralysis and spontaneous 
abortion to pregnant women (M.D. Drechsler et al. ,2008) .   Other application of MAb 
is in chromatographic separations to purify protein molecules.  
 
Hybridomas, hybrid between myeloma and B-lymphocytes developed in 1970s 
capable of the continuous production of monoclonal antibodies (M. Butler, 2004).  
Myeloma is cancerous cell which readily cultivated and have infinite lifespan while B-
lymphocytes able to synthesis single antibody (Prescott et al. 2005).   Up until 2004, 
more than two dozen antibody-based products commercially available. 
  
2 
 
Figure 1.1.1: Development of monoclonal antibody from 1975 until 2002 
(A.C.A. Roque et al., 2004) 
 Upstream process involved cell line development, media optimization and cell 
culture optimization (Feng Li, Joe X. Zhou et al. 2005).  Upstream process has improved 
100 folds for the last 15 years resulted from improvement in expression technology and 
process optimization (J.R. Birch, A.J. Racher, 2006), especially feeding strategies.  
Scaling-up antibody manufacturing process usually has mixed opinion, either increase 
size or increase number of reactor because chemical process parameter is not very 
reliable in scaling up biological process.  
 This question is solved by using integrated flow sheet and process simulation. 
SuperPro Designer® (SPD) developed by Intelligen Inc. is suitable software for 
providing computing environment because it more on bioprocess operation compared to 
Aspen BPSTM   which focused on chemical process (S.A. Rouf et al. 2001).  Application 
of computer aided simulation has been slow in biopharmaceutical industries but it has 
gained popularity. It able to reduces time and cost on building pilot-scale plant. 
Simplicity and fast setup are key advantages in using SPD but, user unable to build 
customized model (S.S Farid et al.,2007).    
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1.2       Problem Statement 
 Cost of producing MAb at large scale is extremely high.  S.S Farid (2006) 
reported $660 to $1580/ft2 and $1756 to $4220/L invested on antibody manufacturing 
site with total site capacities of 2000 L to 20000 L.  This investment does not account for 
miscellaneous cost such as clinical testing, validation and approval of the product.  
 Literatures [L.H. Stanker et al., 2008, M.D Drechsler et al., 2008] have shows 
slowest step in upstream process is cell line development where it can take 14 to 30 days 
to develop. Mammalian expression system such as mouse myeloma (NS0) and Chinese 
hamster ovary is the most effective way in generating MAb, yet it is very costly (A.C.A 
Roque et al., 2004) while molecular pharming ( extracting MAb directly from transgenic 
animals and plant) has shown no clinical result even though it has lower capital cost.   
  Expression error is also common problems in MAb production such as error in 
glycosylation (C. Kontoravdi et al. 2007) allowing degradation of processed antibody 
and increased sensitivity of genetically modified cells to the surrounding (E. Jain, A. 
Kumar, 2008). Obstacles encountered in scaling up are where parameter optimization 
such as pH, temperature, agitation rate, oxygen supply control that been ignored at bench 
scale (less than 5 L of culture).  Limited data on growth rate also another problem, 
causing optimization based on trial-and-error. Shuler and Kargi (2002) write; in larger 
scale, it is difficult to maintain homogeneity and change in culture itself due to increase 
time of culture.  
1.3        Objectives 
1.3.1 To approximate hybridoma viable cell growth rate by comparing simulation data 
and real-time data on bench-scale fermentation. 
1.4       Scope of Study 
Model for this study is hybridoma used to cultivate antibody towards C-cell 
hyperplasmic (CCH), an inherent disease, which able to cause death to month year old 
infant, paralysis and sexual deficiency.  Simulation of this process limited to 
hybridoma’s unstructured model of cell metabolism towards glucose and glutamine. 
Simulation is conduct by assuming no external disturbance.  Material and energy balance 
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done by using unstructured growth model i.e. balance around fermenter and all 
parameter tested limited to the features provided by SuperPro® Designer 6.0 build 11. 
 
 
1.5       Rationale and Significance 
This study has potential in minimizing economical losses by replicating 
sensitivity of cell and properties of media into integrated flow sheet, aiding analysis on 
proposed change in MAb’s production by predicting the results before process scaling-
down to ensure its feasibility.  Rate equation gained from this study approximate real-
time data; it will decrease number of bench-scale experiments require to investigate 
essential parameters for large-scale operation.       
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CHAPTER 2 
LITERATURE REVIEW 
2.1       Dynamic Modeling and Simulation 
Main source of nutrients for mammalian cell culture are glucose and 
glutamine. Metabolism of both substrates is related via TCA cycle (Maria J.G et al. 
2000). Research strategy proposed by C. Kontoravdi et al. 2004 are proposing 
mathematical model for growth, gathering experimental data and use it to validate 
the model, build a robust model to explain the growth; in sequence.  C. Kontoravdi 
et al. 2007 by modeling specific cell growth rate based on concentration of 
substrates (glutamine and glucose) and metabolites (ammonia and lactate).  Typical 
modeling of hybridoma metabolism involved glutamine and glucose as elementary 
reaction for simplification, making it feasible for optimization process. Another 
view (R. Pörtner and T. Schäfer, 1996) says modeling on those two components 
because of ease of analysis. Assumption made when deriving dynamic model for 
inoculums are cells grow exponentially, isothermal operation, liquid density is 
constant, treating solid (biomass) and liquid as homogenous (Seborg, 2004).  
Simplification is made by using unstructured growth model for computational 
tractability. Assumptions made in solving this equation are specific growth rates 
and consumption rates were constant during exponential phase (L.Legazpi et al. 
2005) as described in Table 2.1.1. S.S. Ozturk et al. (1991) reported meaningful 
kinetic parameter can be obtained in absence of lag phase and meticulous selection 
on time span of exponential phase.  
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Table 2.1.1: Kinetic parameters obtained (L. Legazpi et al., 2005) 
 
 
Equation 2.1.1: Unstructured model of growth (C. Kontoravdi et al. 2007) 
 
Equation 2.1.2:  Rate of growth applied in SPD 
 
 This is necessary to create model based on stoichiometry that is useful for 
studying relative activity of pathways under various culture conditions. However, 
this model unable to explain regulation and control of cellular activity which only 
be described by less available dynamic model (J.  Gao et al. 2007). Dynamic 
model as explained by D.B.F. Faraday et al. 2001 employs genetic control over 
cell cycle regulation.  C. S Sanderson et al. 1999 reported dynamic model require 
manual tuning since available automatic estimation routines is limited. S.S. Farid 
(2006) view dynamic model from economy as tool relating time –dependent 
operation with discrete simulation techniques that provide more realistic schedule. 
Prediction is relatively poor and J. Gao et al. 2007 conclude identification of 
reaction kinetics is crucial because of nonlinearity and over-parametrization of 
model. C.S Sanderson et al. 1999 reported too, modeled cell has no stationary 
phase and some data shows linearity with the model. The main difficulty in 
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modeling hybridoma cell is lacks of literature but, parameters from Chinese 
Hamster Ovary (CHO) applicable as CHO cells also produce and glycosylate 
MAbs. 
 
 
Figure 2.1.1:  Model system of mammalian cell that include glucose (S1), 
glutamine (S2), cell density (X) and enzyme (ei) (Maria J.G. et al. 2000) 
 
 
Figure 2.1.2: Metabolic network of hybridoma (J.Gao et al 2007) 
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Table 2.1.2: Fundamental macro reaction of mammalian cell culture (J. 
Gao et al. 2007) 
 
Figure 2.1.1, Figure 2.1.2 and Table 2.1.2 shown above are consistent with 
finding by D.B.F Faraday suggesting glutamine as source of energy and glucose as 
source of biomass. This statement agreed with S.S Ozturk et al (1991) stating 
glutamine as major source of energy and growth ceased when it depleted. There is 
contradiction between D.B.F Faraday et al. (2001) and J. Gao et al. (2007) where 
Faraday assume glutamine consumption to be in zero-order and glucose 
consumption in first-order while J. Gao using Monod kinetics in his research. 
H.Znad et al. (2004) explained kinetic parameters such as oxygen transfer are 
scale-dependent. Maria J.G et al. (2000) modeling is consistent with modeling by 
Y.H. Guan and R.B. Kemp (1999) by omitting micronutrients and minor 
catabolites that does not have effect on enthalpy recovery as shown in Equation 
2.1.3 and Table 2.1.3. 
 
 
Equation 2.1.3: Growth reaction (Y.H. Guan, R.B. Kemp, 1999) 
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Table 2.1.3: Catabolic reaction with condition simplification (Y.H. Guan 
and R.B. Kemp, 1999) 
 
 This will determine environment of bioreactor as time length of culture 
have change (Shuler and Kargi, 2002). Cell death can occurred in two ways, 
apoptosis (programmed cell death under genetic control) and necrosis 
(disintegration of cell by external stress); both caused by substrate limitation and 
metabolite inhibition, respectively (R. Pörtner and T. Schäfer, 1996) as illustrated 
in Table 2.1.4.  
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Table 2.1.4: Various correlations of kinetic parameters (R. Pörtner and T. Schäfer, 
1996) 
2.2       Scale-up and Optimization 
Bioreactor should be designed to provide both low shear to cells and 
adequate mass transfer between nutrient or waste and cells to achieve high cell 
density (E. Jain and A. Kumar, 2008).  B.N Murthy et al. (2007) emphasis 
performance of reactor involving suspended solid greatly influences by dispersion 
of gas and solid particles as reaction occurred between dissolved gas and solid with 
liquid as inert.  Scale-up by using geometric similarity require equality in agtation 
power per volume, volumetric oxygen mass transfer coefficient, maximum shear 
stress and mixing time (Solá and Gódia, 1995). Heat transfer equipment among 
equipment facing difficulties in scale-up 
2.2.1    Stirred tank bioreactor 
Shuler and Kargi (2002) and E. Jain and A. Kumar (2008) agreed reactor 
with internal agitation suitable for commercial purpose because of flexibility and 
high mass transfer coefficient. Flexibility come from ease of changing mechanical 
part especially impeller; position and rotation speed of impeller influence mass 
transfer coefficient by adjusting height of impeller.  
 
At higher position or low rotational speed, impeller virtually has no effect 
on bubbles deformation as bubbles may avoid impeller (M. Martin et al., 2008, part 
1). Figure below shows influence on bubbles’ formation time by type of impeller 
and power input. Ruston turbine has been considered most stable because surface 
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aeration increase with position of the impeller and bubbles break up due developed 
flow under the impeller (M. Martin et al.,2008, part 2) as shown in Figure 2.2.1.1. 
For power input less than 0.1 W/kg, the mass transfer rate is given by the rising 
bubbles from non-stirred fluid. From 0.1 to 1 W/kg, stirring is not crucial in mass 
transfer mechanism and mass transfer rate increase with dissipated energy yet, 
remain stable.  Simulation using FLUENT 6.25 run by B.N Murthy et al. (2007) on 
three impeller designs as shown in Table 2.2.1.1 shows amount of settling solid in 
a reactor decrease as rotational speed increase but it have small effect near the 
surface of liquid. Each design develops unique flow pattern meaning different 
efficiency because flow pattern is essential in deforming bubbles.    
Another factor influence efficiency of fermenter is gas flow rate.  At larger 
gas flow rate, time taken for bubbles formation decreased slightly (M.Martin et al., 
2008, Part 1). Reduces in solid’s cloud height observed by B.N. Murthy et al. 
(2007) as solid settle down when superficial gas velocity decreased. Comparing 
two-holes and one-holes sparger, two-holes sparger require less energy input since 
bubbles formed is small and has large contact area, improving mass transfer. Chisti 
(1993) explain scale-up based on bulk flow have advantage in keeping aeration rate 
low because breakup of bubbles in not necessary. Particle size also have important 
role in determining critical speed of impeller because at smaller size, it has high 
homogeneity with medium, thus less energy required to suspend the solid. 
 
 
Table 2.2.1.1: Geometric details of stirred tank reactor (B.N. Murthy et al. 
2007) 
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Figure 2.2.1.1: Influence of impeller and power input on formation time of 
bubbles (M.Martin et al. 2008, Part 1) 
 Axial flow hydrofoil agitator is used to disperse gas (E. Jain and A. 
Kumar, 2008) because it has lower energy demand and reduced maximum shear 
rate (Shuler and Kargi, 2002). Comparing finding on aeration and agitation effect 
by Chisti (1993) with review by E.Jain and A.Kumar (2008), hybridoma can 
withstand high shear rate in reactor volume up to 0.3 m3. Hybridoma cells able to 
withstand turbulence flow regime in bioreactor. 
2.2.2       Optimization 
   Fed-batch process most common in production of MAb ( J.R Birch and 
A.J Racher, 2006) and analysis using Monte Carlo simulation shows fed-batch has 
higher reward/risk ratio compared to cell perfusion system (S.S Farid, 2006). 
Optimization of feed based on trial-and-error iteration on addition and depletion of 
nutrients [J.R Birch and A.J Racher, 2006; E. Jain and A. Kumar, 2008].  
Optimization result as shown in Figure 2.2.2.1. Inhibition effect by ammonia and 
